{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:03:59Z","timestamp":1773299039671,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009575","name":"Jacques and Gloria Gossweiler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009575","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.toxicon.2017.08.014","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:15:17Z","timestamp":1502756117000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Recent developments in clinical trials of botulinum neurotoxins"],"prefix":"10.1016","volume":"147","author":[{"given":"Antoniangela","family":"Cocco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-0006","authenticated-orcid":false,"given":"Alberto","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2017.08.014_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1015291021312","article-title":"Assessing health status and quality-of-life instruments: attributes and review criteria","volume":"11","author":"Aaronson","year":"2002","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.toxicon.2017.08.014_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrneurol.2016.86","article-title":"Clinical guidelines: No more mistaken identities for botulinum neurotoxins","volume":"12","author":"Albanese","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jnnp.60.6.693-a","article-title":"Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients","volume":"60","author":"Albanese","year":"1996","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2017.08.014_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jama.2016.14617","article-title":"OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial","volume":"316","author":"Amundsen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.toxicon.2017.08.014_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.toxicon.2017.08.014_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/WNF.0000000000000107","article-title":"Comparison between Dysport and prosigne in the treatment of cervical dystonia","volume":"38","author":"Barbosa","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib7","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","article-title":"Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons","volume":"16","author":"Bomba-Warczak","year":"2016","journal-title":"Cell Rep."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.toxicon.2017.08.014_bib8","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1524-4725.2010.01711.x","article-title":"Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines","volume":"36","author":"Brandt","year":"2010","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2017.08.014_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/head.12250","article-title":"An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine","volume":"54","author":"Cady","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2017.08.014_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00403-013-1380-3","article-title":"Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach","volume":"305","author":"Campanati","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.toxicon.2017.08.014_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejpn.2016.04.008","article-title":"Safety profile of incobotulinum toxin A [Xeomin((R))] in gastrocnemious muscles injections in children with cerebral palsy: randomized double-blind clinical trial","volume":"20","author":"Carraro","year":"2016","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/head.12372","article-title":"CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine","volume":"54","author":"Cernuda-Morollon","year":"2014","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2017.08.014_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","article-title":"OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine","volume":"156","author":"Cernuda-Morollon","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2017.08.014_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00266-008-9151-9","article-title":"Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck","volume":"32","author":"Chajchir","year":"2008","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.toxicon.2017.08.014_bib15","first-page":"1743","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cote","year":"2005","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib17","doi-asserted-by":"crossref","first-page":"e20152830","DOI":"10.1542\/peds.2015-2830","article-title":"AbobotulinumtoxinA for equinus foot deformity in cerebral palsy: a randomized controlled trial","volume":"137","author":"Delgado","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2017.08.014_bib18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.toxicon.2017.08.014_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00702-013-1076-z","article-title":"Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox((R))) and incobotulinumtoxinA (Xeomin ((R))","volume":"121","author":"Dressler","year":"2014","journal-title":"J.\u00a0Neural Transm. (Vienna)"},{"key":"10.1016\/j.toxicon.2017.08.014_bib20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1526-4610.2008.01215.x","article-title":"Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine","volume":"48","author":"Durham","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.toxicon.2017.08.014_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1542\/peds.2015-0749","article-title":"Safety of botulinum toxin type a for children with nonambulatory cerebral palsy","volume":"136","author":"Edwards","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2017.08.014_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.22452","article-title":"Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review","volume":"24","author":"Elia","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2017.08.014_bib23","first-page":"1663","article-title":"The role of polymyography in the treatment of cervical dystonia","volume":"263","author":"Erro","year":"2016","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-013-1526-2","article-title":"The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm","volume":"35","author":"Esposito","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.toxicon.2017.08.014_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2014.09.034","article-title":"Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia","volume":"21","author":"Ferreira","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.toxicon.2017.08.014_bib26","first-page":"38","article-title":"Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines","volume":"11","author":"Glogau","year":"2012","journal-title":"J.\u00a0Drugs Dermatol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib27","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1111\/j.1524-4725.2006.32335.x","article-title":"Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study","volume":"33","author":"Glogau","year":"2007","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.toxicon.2017.08.014_bib28","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib29","article-title":"An academic debate: onabotulinumtoxina for chronic migraine: PREEMPT-derived vs \u201ccustomized\u201d dosing\/injection paradigm","author":"Green","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.08.014_bib30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/lary.24456","article-title":"Effects of botulinum toxin A on patient-specific keloid fibroblasts in\u00a0vitro","volume":"124","author":"Haubner","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.toxicon.2017.08.014_bib31","author":"Herbert"},{"key":"10.1016\/j.toxicon.2017.08.014_bib32","first-page":"1665","article-title":"The role of polymyography in the treatment of cervical dystonia: the authors reply","volume":"263","author":"Jinnah","year":"2016","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib33","first-page":"1188","article-title":"Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes","volume":"263","author":"Jinnah","year":"2016","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib34","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib35","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dmcn.12739","article-title":"Botulinum toxin A injections and occupational therapy in children with unilateral spastic cerebral palsy: a randomized controlled trial","volume":"57","author":"Lidman","year":"2015","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/dmcn.13286","article-title":"Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase","volume":"59","author":"Montastruc","year":"2017","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.parkreldis.2013.01.018","article-title":"Cervical dystonia: improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography","volume":"19","author":"Nijmeijer","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.toxicon.2017.08.014_bib38","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/CIRCEP.115.003199","article-title":"Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery: one-year follow-up of a randomized pilot study","volume":"8","author":"Pokushalov","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2014.04.062","article-title":"Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study","volume":"64","author":"Pokushalov","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/WNF.0b013e3181c46f48","article-title":"A\u00a0prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia","volume":"33","author":"Quagliato","year":"2010","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib41","article-title":"Direct central nervous system effects of botulinum neurotoxin","author":"Restani","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.08.014_bib42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/WNF.0000000000000101","article-title":"A\u00a0comparison of botox 100 U\/mL and Dysport 100 U\/mL using dose conversion ratio 1: 3 and 1: 1.7 in the treatment of cervical dystonia: a double-blind, randomized, crossover trial","volume":"38","author":"Rystedt","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WNO.0000000000000110","article-title":"A\u00a0direct comparison of onabotulinumtoxina (Botox) and IncobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm: a split-face technique","volume":"34","author":"Saad","year":"2014","journal-title":"J.\u00a0Neuroophthalmol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jocd.12134","article-title":"Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial","volume":"14","author":"Shaarawy","year":"2015","journal-title":"J.\u00a0Cosmet. Dermatol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/jnnp-2013-307149","article-title":"Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT","volume":"86","author":"Silberstein","year":"2015","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2017.08.014_bib46","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2017.08.014_bib47","article-title":"Botulinum toxin for chronic migraine: clinical trials and technical aspects","author":"Tassorelli","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.08.014_bib48","doi-asserted-by":"crossref","first-page":"e0151316","DOI":"10.1371\/journal.pone.0151316","article-title":"Safety and efficacy of botulinum toxin to preserve gland function after radiotherapy in patients with head and neck cancer: a prospective, randomized, placebo-controlled, double-blinded phase I clinical trial","volume":"11","author":"Teymoortash","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2017.08.014_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0707375","article-title":"Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells","volume":"152","author":"Teymoortash","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2017.08.014_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast. Surg."},{"key":"10.1016\/j.toxicon.2017.08.014_bib51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/1090820X13482938","article-title":"Effects of botulinum toxin type A on expression of genes in keloid fibroblasts","volume":"34","author":"Xiaoxue","year":"2014","journal-title":"Aesthet. Surg. J."},{"key":"10.1016\/j.toxicon.2017.08.014_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mds.26085","article-title":"Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study","volume":"30","author":"Yun","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2017.08.014_bib53","doi-asserted-by":"crossref","first-page":"275e","DOI":"10.1097\/PRS.0b013e3181b98ee7","article-title":"Intralesional botulinum toxin type A injection as a new treatment measure for keloids","volume":"124","author":"Zhibo","year":"2009","journal-title":"Plast. Reconstr. Surg."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T05:29:51Z","timestamp":1659331791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010117302507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":53,"alternative-id":["S0041010117302507"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.08.014","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent developments in clinical trials of botulinum neurotoxins","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}